Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 3NIH 2INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Breast Neoplasms 20Neoplasms 9Neoplasm Metastasis 5Carcinoma, Non-Small-Cell Lung 3Stomach Neoplasms 2Unspecified Adult Solid Tumor, Protocol Specific 1Solid Tumors 1Solid Malignancies 1Recurrence 1Pancreatic Neoplasms 1Lung Neoplasms 1Esophageal Neoplasms 1Endometrial Neoplasms 1Carcinoma 1Advanced Solid Tumors 1Adenocarcinoma Of Esophagus 1

Interventions

PR-104 3apomine 2N-(4-(3-(1H-1,2,4-triazol-1-yl)-4-(3,4,5-trimethoxybenzoyl)phenyl)thiazol-2-yl)-2-amino-3-methylbutanamide 2tesetaxel 1ixabepilone 1intoplicine 1fluoromisonidazole 1eribulin 1bempegaldesleukin 1HhAntag691 1Granulocyte Colony-Stimulating Factor 1Gemcitabine 1Filgrastim 1Docetaxel 1Capecitabine 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Unspecified Adult Solid Tumor, Protocol Specific × ixabepilone × Clear all
NCT00004927 2017-01-30

BMS-247550 in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy

R-Pharm

Phase 1 Completed
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡